Specialties

In this week's Homerun Slides, the action and safety of the type 2 medication, bromocriptine.

In part one of this interview on the use of amniotic membrane as a possible treatment for diabetic ulcers, Diabetes in Control publisher first talks with Dr. Don Fetterolf about the prevalence of diabetic foot ulcers, the impact of the condition and the groups who are affected.

Study of 40-year trend focused on three ethnic groups prone to dental complications.

National cohort study examined events in Medicare beneficiaries.

In this week's Homerun Slides, the natural history of type 2 diabetes and factors contributing to CV risk.

To wrap up this series, we present the final two installments of the conversation between Diabetes in Control Publisher Steve Freed and Dr. Richard Bergman. In part 5, Steve learns more about the institute founded and led by Dr. Bergman at Cedars-Sinai. In part 6, Steve asks what is more important — blood pressure or blood glucose levels?

In this week's Homerun Slides, the vicious circle of hyperinsulinemia in patients with type 2 diabetes.

Diabetes in Control Publisher Steve Freed and Dr. Richard Bergman discuss his ADA presentations — the relationship between diabetes and altitude, and the role of kidneys in diabetes research. Steve also asks why the degredation of insulin in the liver is important in the pathogenesis of diabetes. Dr. Bergman is the founder and director of Diabetes and Obesity Research Institute, Biomedical Sciences at Cedars-Sinai in Los Angeles. He introduced the use of engineering principles to understand the pathogenesis of diabetes.

In this week's Homerun Slides, we begin a new series on the role of anti-diabetes medications in reducing cardiovascular risk and outcomes in diabetes patients.

A known link between low testosterone levels and decreased insulin sensitivity could lead to a treatment for men with type 2.